Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, COMPRISING, AS ACTIVE INGREDIENT, LACTIC ACID BACTERIA FERMENTATION SOLUTION OF MORI FRUCTUS EXTRACT
Document Type and Number:
WIPO Patent Application WO/2023/177248
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating Alzheimer's disease, comprising, as an active ingredient, a lactic acid bacteria fermentation solution of a Mori Fructus extract. The lactic acid bacteria fermentation solution of a Mori Fructus extract improves memory and cognitive function, and thus can exhibit excellent effects in preventing, alleviating or treating Alzheimer's disease.
Inventors:
KOO BYUNG SOO (KR)
KIM KWANG KI (KR)
LIU QUANFENG (KR)
KIM MAN GI (KR)
KANG SEOK-SEONG (KR)
KIM KWANG KI (KR)
LIU QUANFENG (KR)
KIM MAN GI (KR)
KANG SEOK-SEONG (KR)
Application Number:
PCT/KR2023/003558
Publication Date:
September 21, 2023
Filing Date:
March 17, 2023
Export Citation:
Assignee:
DONGGUKUNIVERSITY WISE CAMPUS IND ACADEMY COOPERATION FOUNDATION (KR)
UNIV DONGGUK IND ACAD COOP (KR)
UNIV DONGGUK IND ACAD COOP (KR)
International Classes:
A61K36/605; A61P25/28
Foreign References:
| KR20120093799A | 2012-08-23 | |||
| KR20200130800A | 2020-11-20 | |||
| KR20150051624A | 2015-05-13 | |||
| JP2008100969A | 2008-05-01 |
Other References:
"Ph.D. thesis", 31 January 2022, DONGGUK UNIVERSITY, KR, article KANMANI, SUGANYA: "Extract of Morus alba Linnaeus fermented with Lactobacillus DF01 attenuates neuroinflammatory response in vitro and improves memory impairment via modulation of gut microbiota and Aβ level in AD mice model", pages: 1 - 68, XP009549088
Attorney, Agent or Firm:
PCR INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: